Can you provide a concise summary of the Gut journal article titled "Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility"?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Genetic Dissection of Stool Frequency: Vitamin B1 and Gut Motility Pathways

Key Findings

This landmark 2026 multiancestry genome-wide association study (GWAS) of 268,606 individuals reveals that vitamin B1 (thiamine) metabolism plays a previously unrecognized but therapeutically actionable role in controlling gut motility, with direct implications for IBS and other dysmotility disorders 1.

Core Genetic Discoveries

The study identified 21 independent genetic loci associated with stool frequency (an indirect measure of gastrointestinal transit), including 10 novel signals. The heritability of stool frequency was comparable across populations (7.0% in Europeans, 5.6% in East Asians) 1.

Critical Pathways Implicated:

  • Vitamin B1 metabolism: Fine-mapping converged on two key genes:

    • SLC35F3 (thiamine transporter)
    • XPR1 (phosphate exporter essential for thiamine activation)
    • Both showed single-variant causal effects on stool frequency 1

  • Bile acid synthesis: KLB gene involvement 1

  • Cholinergic signaling: COLQ gene involvement 1

Clinical Validation of Thiamine Effects

In 98,449 UK Biobank participants, the study demonstrated:

  • Thiamine intake positively associated with stool frequency (p<0.0001)
  • A combined SLC35F3/XPR1 genotype score significantly modulated this dietary effect (p<0.0001)
  • This represents a gene-diet interaction where genetic variants in thiamine metabolism pathways determine individual responses to dietary thiamine 1

Disease Correlations and Causal Relationships

The genetic analysis revealed:

  • Strong genetic correlations with gastrointestinal disorders (rg=0.18-0.47) and psychiatric conditions (rg=0.18-0.47)
  • Causal effects on IBS: Mendelian randomization supported that genetic variants affecting stool frequency causally influence IBS risk 1
  • Novel cardiovascular correlations (rg=0.12-0.14), supported by drug signature enrichment analyses 1

Mechanistic Context

This aligns with established pathophysiology where colonic transit correlates inversely with stool consistency and frequency, though the thiamine pathway represents an entirely novel therapeutic target 2. The bile acid pathway findings complement existing knowledge that bile acid malabsorption affects 28.1% of IBS-D patients 3.

Translational Implications

The identification of vitamin B1 metabolism as a modifiable factor in gut motility provides a readily actionable therapeutic avenue, as thiamine supplementation is safe, inexpensive, and widely available. The genetic stratification by SLC35F3/XPR1 variants suggests potential for personalized nutrition approaches in dysmotility syndromes 1.

Clinical Pitfalls to Avoid:

  • The study used stool frequency as a proxy for transit—not all motility disorders manifest primarily as frequency changes
  • Genetic effects are modest (7% heritability), indicating multifactorial causation
  • The thiamine-stool frequency relationship requires validation in controlled intervention trials before routine clinical implementation

References

Related Questions

Are irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), small intestinal bacterial overgrowth (SIBO), and beriberi all treatable with thiamine (vitamin B1)?
Can a high-fiber diet improve constipation?
What are the recommended dietary and lifestyle measures for managing constipation?
What is the recommended management for constipation associated with gut‑brain axis dysfunction?
What are the short‑term and long‑term management strategies for constipation?
Is the heart rate typically elevated in patients with a bifascicular block?
How should I manage a patient with three days of fatigue, nausea, and vomiting who has leukopenia (white blood cell count 1.55 ×10⁹/L) with otherwise normal complete blood count and comprehensive metabolic panel?
What is the appropriate treatment for Clostridioides difficile infection complicated by paralytic ileus?
Is hydrogen peroxide appropriate for use in a diabetic foot ulcer, and if so, how should it be applied?
Why do some providers prescribe valacyclovir 1 gram twice daily (BID) for 10 days?
Why do clinicians prescribe valacyclovir 1 g twice daily for 10 days for herpes zoster, and does it cause arrhythmias?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.